Piermont Capital Management Inc. - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,412,000
-36.2%
116,005
-16.6%
0.45%
-36.0%
Q4 2015$2,212,000
+2.8%
139,020
-1.0%
0.70%
+0.1%
Q3 2015$2,152,000
-36.0%
140,360
+1.4%
0.70%
-30.8%
Q2 2015$3,364,000
+24.2%
138,380
+18.8%
1.02%
+23.0%
Q1 2015$2,709,000
+661.0%
116,520
+722.3%
0.82%
+549.6%
Q4 2014$356,00014,1700.13%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders